O. Holz (Hannover, Germany), C. Bingle (Sheffield, United Kingdom), M. Brodlie (Northumberland, United Kingdom)
Late-breaking abstract: Repeated analysis of alpha-1-antitrypsin concentrations in sputum, lavage and serum of smokers with and without COPD
O. Holz, S. Roepcke, G. Lauer, N. Krug, P. Ernst, C. Diefenbach, G. Lahu, J. Hohlfeld (Hannover, Konstanz, Germany)
|   |
Late-breaking abstract: Repeated bronchoconstriction without additional inflammation is sufficient to induce airway remodelling in asthma
C. Grainge, J. Ward, G. Lahiff, V. Dulay, L. Lau, D. Davies, P. Howarth (Southampton, United Kingdom)
| |
Late-breaking abstract: Role of IL-13-producing BLT1-positive CD8 T cells in asthmatic airway obstruction
A. Dakhama, M. L. Collins, D. Y. M. Leung, E. Goleva, R. Alam, E. R. Sutherland, R. J. Martin, E. W. Gelfand (Denver, United States Of America)
| |
In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response
F. Stellari, F. Ricci, P. Caruso, L. Calza‘, R. Ruotolo, L. Lorenzini, G. Villetti (Parma, Bologna, Italy)
| |
Comparison of distal lung innervation in human and guinea pig precision-cut lung slices (PCLS)
M. Schlepütz, A. D. Rieg, M. Bernau, J. W. Spillner, A. Perez-Bouza, R. Autschbach, S. Uhlig, C. Martin (Aachen, Germany)
| |
The clinical significance of markers of endothelial dysfunction (ED) inprogression of idiopathic interstitial pneumonias (IIP)
A. Ponomarev, E. Popova, M. Lebedeva, S. Bolevich, V. Osypencko (Moscow, Russian Federation)
| |
Increased polysialylation in lung tissue of patients with idiopathic pulmonary fibrosis
C. Ulm, M. Korfei, S. Mueller, S. Rinné, H. Geyer, R. Gerardy-Schahn, M. Muehlenhoff, A. Guenther, R. Geyer, S. Galuska (Giessen, Marburg, Hannover, Germany)
| |
Human neutrophil peptides as biomarkers for monitoring respiratory functional impairment in sarcoidosis
G. Paone, M. Rulli, A. Leone, P. Graziano, V. Conti, I. Cammarella, G. Galluccio, A. Sebastiani, G. Lucantoni, G. Puglisi (Rome, Milan, Italy)
| |
A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease?
S. Weldon, P. McNally, C. Scott, S. Randell, P. McCray, C. Taggart (Belfast, United Kingdom; Dublin, Ireland; Chapel Hill, United States Of America)
| |
Immune and inflammatory responses in induced sputum (IS) in Anderson Fabry disease (AFD), COPD and healthy volunteers
N. Shafi, D. Hughes, A. Mehta, C. Smith, M. Lipman (London, United Kingdom)
| |
Surfactant protein D is critical for local immunomodulation in the distal lung
M. Beers, D. Jain, F. Blank, Y. Tomer, C. von Garnier (Philadelphia, United States Of America; Bern, Switzerland)
| |
Increased mast cell numbers in alveolar parenchyma in infants with respiratory viral infections
C. Andersson, A. Al-Garawi, T. Mauad, J. Reed, M. Mori, A. Bergqvist, M. Jordana, L. Bjermer, J. Erjefält (Lund, Sweden; Hamilton, Canada; São Paulo, Brazil; Bethesda, United States Of America)
| |
Establishment of reference values for differential cell counts in nasal lavage of healthy young adults
Y. Xie, J. Xie, K. Lai, N. Zhong (Guangzhou, China)
| |
The dietary antioxidant quercetin boosts pulmonary antioxidant defenses
A. Boots, C. Albrecht, B. Olga, M. Hullmann, I. Foerster, G. Haenen, A. Bast, R. Schins (Duesseldorf, Germany; Maastricht, Netherlands)
| |
Clinical evaluation of angiogenesis and coagulation in pulmonary sarcoidosis
E. Popova, M. Lebedeva, A. Ponomarev, S. Bolevich, V. Osypencko (Moscow, Russian Federation)
| |
Detection of serum anti-endothelial cell antibodies (AECA) in COPD rats
Y. Lin, Q. Zhang, X. F. Ling, S. Q. Sun (Nanjing, China)
| |
CD146 in the pathogenesis of COPD
A. Kratzer, J. Salys, H. W. Chu, M. Zamora, L. Taraseviciene-Stewart (Denver, United States Of America)
| |
Effects of steroids on inflammatory cell number and function in the proximal and distal airways
G. Rankin, S. Wilson, D. Hall, J. Warner (Southampton, Stevenage, United Kingdom)
| |